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Background: Plant-phenolics and flavonoids, including gallic acid, quercetin and rutin, are considered as safe inhibitors for 
α-glucosidase. This study aimed to compare antioxidant and α-glucosidase inhibitory activities of gallic acid (GA), quercetin 
(QUE) and rutin (RUT). 
Materials and Methods: Pure compounds of GA, QUE, and RUT were used. Their antioxidant and inhibitory activity on 
α-glucosidase were investigated spectroscopically, including their kinetic analysis and interaction mechanism by docking 
simulation. 
Results: All the tested compounds (GA, QUE, and RUT) showed good antioxidant activity better than the standards ascorbic 
acid (AA) and butylated hydroxytoluene (BHT), with QUE showing the highest antioxidant activity based on  2,2-diphenyl-
1-picrylhydrazyl (DPPH) radical scavenging activity. Based on their reducing properties, the activities of the compounds 
follow the following order: AA > GA > BHT > QUE > RUT. Both GA and RUT induced a competitive type of inhibition, with 
activities stronger than acarbose (IC50 = 823 μg/mL), whereas QUE inhibited in a mixed type manner. The IC50 of GA, QUE, 
and RUT were 220.12, 65.52, and 224.55 μg/mL respectively. The results obtained from molecular docking indicate that all 
compounds have affinity in the active site pocket of α-glucosidase, with the hydrogen bond being the major force involved 
in each compound binding to the enzyme.
Conclusion: In conclusion, QUE has better antioxidant and α-glucosidase inhibitory activity than GA and RUT.  This work 
provides insights into the interactions between GA, QUE, and RUT and α-glucosidase. 
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Introduction
Plant products are potentially a good source for screening 
α-glucosidase inhibitors. Flavonoids and phenolics which 
are widely existed in various plants have been reported to 
exhibit inhibitory effect on α-glucosidase, such as luteolin1, 
kaempferol2 and gallic acid (GA)3. GA, quercetin (QUE) and 
rutin (RUT) are commonly used as standard compounds for 
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total phenolic and/or total flavonoid measurements. Their 
inhibitory activities on α-glucosidase are not yet compared 
experimentally. In the present study, the antioxidant 
capacities and α-glucosidase inhibitory activities of these 
compounds, including their type of inhibitions and binding 
interactions with the enzyme were reported.
 GA or 3,4,5-trihydroxybenzoic acid (Figure 1) is a 
plant-derived phenolic acid. GA exerts many biological 
effects such as antioxidant, anticancer, antiviral, 
cardioprotective and anti-diabetic effects.4,5 GA showed 
strong antidiabetic activity both in vitro and in vivo6 and 
its combination with acarbose was recommended for anti-
diabetic therapy.3 Moreover, derivates of GA i.e., methyl 
gallate and propyl gallate showed strong α-glucosidase 
inhibitory activity.3,7 GA extracted from plants have been 
shown to exert strong inhibition on α-glucosidase.8,9
 QUE is a kind of plant flavonoid, whereas RUT is 
a glycoside of QUE (Figure 1). QUE and RUT belong to 
flavonol which are often found in onion, kale, broccoli, 
apples, cherries, berries, black tea, and mango.10,11 Both 
were reported to possess anti-diabetic potentials.12,13 Some 
studies proposed that QUE and RUT exerts its hypoglycemic 
effect through multiple actions including by increasing 
the proliferation of pancreatic β-cells, enhancing insulin 
sensitivity and stimulating insulin secretion.12,14 Further, 
antidiabetic effect of QUE may also involve the protection 
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Figure 1. Molecular structures of acarbose (A), GA (B), QUE (C) and RUT (D).
of β-cells, as were shown by previous in vivo studies.15 In 
addition, QUE and RUT were shown to strongly inhibit 
α-glucosidase.16 
 The aims of this study were to determine and compare 
inhibitory activities of GA, QUE and RUT on α-glucosidase 
and to investigate their binding interaction with the enzyme 
by in vitro and molecular docking studies. Their antioxidant 
capacities were also evaluated.
Materials and methods
The 2,2-diphenyl-1-picrylhydrazyl (DPPH) Free Radical 
Scavenging Activity Assay 
Antioxidant activities of GA (Cat. No. #sc205704, Santa 
Cruz Biotechnology, Dallas, USA), QUE (Cat. No. 
#PHR1488, Sigma-Aldrich, St Louis, USA), RUT (Cat. 
No. #sc204897B, Santa Cruz Biotechnology) and standard 
compounds, ascorbic acid (AA) (Cat. No. #470300-286, 
VWR BDH Prolabo Chemicals, Lutterworth, UK) and 
butylated hydroxytoluene (BHT) (Cat. No. #B1378, Sigma-
Aldrich) were determined based on reported method.17 
Solution of DPPH (Cat. No. #D9132, Sigma-Aldrich) (0.6 
mM in ethanol) was prepared and 1 mL of this solution was 
added to 3 mL of tested compounds at various concentration. 
The reactions were incubated for 30 min in darkness at 
room temperature and the absorbance was read at 517 nm 
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with spectrophotometer Biochrom Libra S-22 (Biochrom, 
Cambridge, UK). Ethanol (3 mL) in place of extract was 
used as control. The percentage inhibition activity was 
calculated according to the following equation:
                                                              =                                 x 100%
A          - Acontrol sample
A         control
DPPH radical 
scavenging activity (%)
Where A control: absorbance of control, A sample: absorbance 
of sample. The percentage of inhibition was plotted against 
concentration to calculate the IC
50
 which is defined as the 
amount of antioxidant required to decrease the inhibition of 
DPPH radical by 50%. The IC
50
 values were expressed as 
μg/mL and compared with the standards.
Reducing Power Activity Assay
Reducing power capacity of GA, QUE, and RUT was 
determined according to reported method.18 The procedure 
was based on the reduction of Fe(III) to Fe(II) reaction. 
Different concentrations of compounds or standards 
(ascorbic acid and BHT) in water (50, 100, and 200 µg/
mL) were prepared. In a test tube, 1 mL of each sample 
solution was mixed with 2.5 mL K3Fe(CN)6 (Cat. No. 
#104971, Merck, Darmstadt, Germany) solution (1% w/v), 
followed by 2.5 mL phosphate buffer (200 mM, pH 6.6). 
The mixture was incubated in a water bath for 20 minutes 
at 50oC. Into the mixture, trichloroacetic acid (Cat. No. 
#T6399, Sigma-Aldrich) solution (2.5 mL, 10% w/v) was 
added and centrifuged for 10 min at 3000 rpm. The upper 
layer of the solution (2.5 mL) was taken out and mixed 
with water (2.5 mL) and FeCl3 (Cat. No. #sc215192, 
Santa Cruz Biotechnology) solution (0.5 mL, 0.1% w/v). 
The absorbance of each sample was read at 700 nm by 
spectrophotometer and compared with the standards.
Total Antioxidant Activity/Phosphomolybdate Assay
Total antioxidant activity of GA, QUE, and RUT was 
determined according to a phosphomolybdate method 
reported previously19. Phosphomolybdate reagent contained 
sulfuric acid (0.6 M), sodium phosphate (28 mM), and 
ammonium molybdate solution (4 mM). Into 3 mL of this 
solution was added 0.3 mL compound solution of standards 
(ascorbic acid and BHT) in water (50, 100, 200 and 400 
µg/mL) placed in capped tubes. The reaction mixture was 
incubated in water bath at 95oC for 1.5 hours and let to cool 
at ambient temperature. The absorbance was measured at 
695 nm using a spectrophotometer and the reading was 
compared with the standards.
α-Glucosidase Inhibitory Activity
The α-glucosidase inhibitory activities of GA, QUE, RUT, 
and acarbose (Cat. No. #1000521, USP, North Bethesda, 
USA) as standard compound were carried out according to 
previous study.20 Briefly, a 50 μL of compound solution at 
different concentrations was mixed with 50 μL phosphate 
buffer (50 mM, pH 6.8) and 50 μL of α-glucosidase (Cat. 
No. #G5003, Sigma-Aldrich) (0.5 unit/mL). After pre-
incubating for 5 min at 37oC, substrate (1 mM p-nitrophenol-
α-D glucopyranoside) (Cat. #N1377, Sigma-Aldrich) was 
added to the reaction mixture and incubated for 20 min at 
37oC. The reaction was stopped by adding 750 μL Na2CO3 
(100 μM). The absorbance was read at 405 nm. For the 
control solution, all procedures were followed except that 
sample was replaced by buffer. The percentage of inhibition 
was calculated using the following equation:
               α-Glucosidase inhibition (%) =                                 x 100%
A          - Acontrol sample
A         control
Where A control: absorbance of control, A sample: absorbance 
of sample. The α-glucosidase inhibitory activity was 
expressed as IC
50
 values (µg/mL) and was determined from 
the graph plotted against the percentage inhibition. Values 
were compared with the positive control acarbose, the 
antidiabetic medicine.
Enzyme Kinetic Assay
GA, QUE, RUT and the positive control, acarbose were 
evaluated for their inhibitory kinetics on α-glucosidase 
activity according to a method described previously.18 
The inhibition type was determined based on the effect of 
different concentrations of each compound on increasing 
concentration of 4-Nitrophenyl-β-D-glucopyranoside 
(p-NPG) (0.25-1.25 mM) as substrate. The study of 
the inhibition type (competitive, uncompetitive, non-
competitive or mixed) was performed using the nonlinear 
regression Michaelis-Menten enzyme kinetics and the 
corresponding Lineweaver-Burk double reciprocal plots 
(1/Vmax  vs 1/[S], as y and x axis, respectively) for each 
concentration of the inhibitor and substrate. The Ki values 
were calculated with Molecular Operating Environment 
Software.
Preparation of Ligands
GA, QUE, RUT, and acarbose were compounds to be used 
for molecular docking simulations on α-glucosidase. All 
of the two dimensional (2D) structures of the compounds 
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were retrieved from PubChem database as an .sdf file and 
were imported into MOE 2010.10 and save as a .pdb file. 
The three dimensional (3D) structures of all ligands were 
obtained from PubChem database with PubChem CID 370 
(GA), 41774 (acarbose), 5280343 (QUE), and 5280805 
(RUT). The optimization of these ligands was performed 
using a Merck molecular force field MMFF94x in MOE.
Molecular Modelling (of α-Glucosidase, GA, QUE, RUT, 
and Acarbose) 
The 3D structures of Saccharomyces cerevisiae 
α-glucosidase are not reported yet. However, the crystal 
structure that has been isolated for Saccharomyces cerevisiae 
is of manosyl-oligosaccahride glucosidase. The amino acid 
sequence of this protein was obtained from NCBI data base 
(http://www.ncbi.nlm.nih.gov/protein/) and the 3D model 
was built using SWISS-MODEL server and the predicted 
template of 3D model was obtained from Protein Data 
Bank. The 3D structures of the protein were validated using 
Ramachandran plot.
Molecular Docking of GA, QUE and RUT with 
α-Glucosidase 
Before the molecular docking was performed, the following 
preparations were conducted, such as addition of hydrogen 
atoms and/or partial charges to the model and minimization 
of unwanted steric effect by keeping heavy atoms fixed. The 
target receptors model of α-glucosidase energy was optimized 
using CHARMM in MOE. Molecular docking between 
ligand and target receptors was performed on the active site 
generated from the MOE-Alpha Site Finder module using a 
wall constraint with radius 7Å. The molecular docking itself 
was carried out using Triangle Matcher placement method 
and a force field refinement. Docking poses were scored 
using the Affinity ∆G scoring method of MOE. Selection 
of lead compound was performed by analyzing the residue 
interactions, hydrogen bonds, and electrostatic interactions 
generated from molecular docking.
Statistical Analysis
All experiments were carried out in triplicates. Results were 
reported as mean±standard deviation (SD). Regression 
method was used to calculate IC
50
 and enzymatic kinetic. 
Results
Three different methods were used to evaluate the antioxidant 
activity of GA, QUE and RUT. For each method, ascorbic 
acid and BHT as standards were also assessed to compare 
the activity. 
 DPPH assay was the method used to assess the radical 
scavenging activity of the compounds. Scavenging free 
radicals is an important mechanism involving antioxidant 
pathway. The results for radical scavenging activities 
(IC
50
) are shown in Table 1. QUE was the best scavenger/
antioxidant among other compounds (GA, RUT, AA and 
BHT). In addition to DPPH assay, the antioxidant activity of 
the compounds was also evaluated based on reducing power 
and total antioxidant activity. In this case, an electron is 
donated from the antioxidant compounds to reduce Fe(III) 
to Fe(II) or Mo(VI) to Mo(V) for reducing power and total 
antioxidant activity assay, respectively. Results are shown in 
Figure 2. Based on these methods, generally, the activities 
of the compounds showed the following order: AA > GA > 
BHT > QUE > RUT. 
 The α-glucosidase inhibition activity of the compounds 
was investigated, and the results are shown in Table 2. All 
the tested compounds, GA, QUE and RU, showed excellent 
inhibition activity on α-glucosidase compared to that of the 
standard acarbose, as indicated by their IC
50
 (μg/mL). Their 
Inhibition
(%)
IC50
(µg/mL)
Gallic Acid 10 20.12 ± 0.01 58.82 ± 0.37
15 24.14 ± 0.09
25 33.31 ± 0.09
43.75 39.05 ± 0.22
62.5 52.79 ± 0.16
Quercetin 1 18.02 ± 0.19 2.71 ± 0.04
2 29.36 ± 4.11
2.5 39.32 ± 0.43
3 69.71 ± 0.20
3.75 74.20 ± 0.61
Rutin 5 25.42 ± 0.14 8.53 ± 0.01
6.25 33.22 ± 0.05
7.5 41.17 ± 0.08
10 62.76 ± 0.16
12.5 77.33 ± 0.10
Ascorbic acid 53.24 ± 0.82
BHT 21.36 ± 0.80
Concentration
(µg/mL)
Table 1. Comparative DPPH radical scavenging activities of 
GA, QUE, RUT and standards (IC50).
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Figure 2. Antioxidant activity measured by phosphomolybdate (A) and reducing power assay (B).
Inhibition
(%)
IC50
(µg/mL)
Gallic Acid 200 16.34 ± 2.00 220.12 ± 5.05
210 25.84 ± 5.58
225 74.98 ± 1.76
250 89.91 ± 10.84
Quercetin 25 19.46 ± 6.71 65.52 ± 2.88
50 32.99 ± 0.44
75 72.22 ± 2.78
125 84.07 ± 1.60
Rutin 200 26.99 ± 3.94 224.55 ± 5.48
225 50.7 ± 9.96
250 75.57 ± 2.54
275 92.81 ± 2.54
Acarbose 823 ± 0.06
Concentration
(µg/mL)
Table 2. IC50 of α-glucosidase inhibition by GA, QUE and RUT.
IC
50
 values were in the range of 65.52 to 224.55, lower than 
IC
50
 of acarbose of 823.00 (Table 2). It was evident that 
QUE was the most active inhibitor. 
 To characterize the type of inhibition of the compounds 
on α-glucosidase, i.e., competitive, noncompetitive, 
uncompetitive, or mixed, the Linewaver–Burk double 
reciprocal plots were generated. The results were shown in 
Figure 3. The LB plots of GA, RUT, and acarbose gave straight 
lines which had different intersection on the X-axis. These 
results suggest a competitive inhibition on α-glucosidase by 
these compounds. Different result was observed for QUE. 
In the presence of increasing concentrations of QUE, the 
Lineweaver–Burk plot generated straight lines which had 
a point of intersection in the second quadrant, indicating 
that the inhibition was of the mixed competitive and non-
competitive type.
 The molecular docking studies were conducted 
in order to understand the binding interaction between 
inhibitors and the enzyme α-glucosidase. Table 3 shows the 
binding energy of four different ligands and the receptor, 
together with the kind of interaction and bond lengths. The 
docking simulations are shown in Figure 4.
 
Discussion
 According to Niedowicz, oxidative stress 
may contribute to the incidence of oxidative related 
complications in diabetes.21 Long term hyperglycemia may 
induce increased production of reactive oxygen species 
(ROS) via non-enzymatic glucose autoxidation, glycation, 
and alterations in poly-ol pathway activity.22 Therefore, in 
the present study, the antioxidant properties of GA, QUE, 
and RUT were evaluated and compared. Phytochemicals 
that possess antioxidant properties were reported to exert 
their antioxidative mechanism by way of reducing oxidative 
species.23 The current study evaluated the reducing 
properties of the compounds by their ability to reduce 
Fe(III) to Fe(II) and Mo(VI) to Mo(V). These assays reflect 
the reducing capability of antioxidant compounds and may 
serve as a significant indicator for antioxidant activity.24 
In both assays, the results revealed that GA possessed the 
strongest reducing capacity compared to QUE and RUT. 
Furthermore, the current study also evaluated antioxidant 
properties of the tested compounds based on their free 
radical scavenging ability. The result found that QUE and 
RUT (flavonoids) were stronger radical scavengers than 
GA (a phenolic compound). The different results obtained 
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Figure 3. Lineweaver-Burk plot of GA (A), Acarbose (B), QUE (C), and RUT (D) on α-glucosidase at different concentration of 
p-NPG.
 ∆G 
(kcal/mol)
K i   
(M) Interaction Residue
Distance 
(Å) 
H-donor Glu 411 3.23
H-donor Asp 215 2.88
H-donor Asp 242 2.74
H-donor Ser 311 2.78
H-donor Leu 313 3.01
H-donor Gln 279 2.79
H-donor Glu 411 2.98
H-acceptor Ser 240 3.3
H-acceptor Ser 241 3.1
H-pi Tyr 158 3.49
Acarbose -5.668 69.664 H-donor Asp 242 2.91
Rutin -8.7832 0.361464
Gallic Acid -4.4458 548.76
Quercetin -6.6711 12.8
Table 3. Energy calculation and H-bond parameter.
in reducing power and DPPH assays could be due to the 
difference in antioxidant mechanism that took place in the 
assays. According to Celik and Arinç, quercetin expressed 
higher antioxidant capacity than its flavonoids derivatives, 
like rutin and naringenin.25 Heijnen, et al., reported that  the 
presence of multiple hydroxyl groups of flavonoid act as 
vigorous scavengers not only for ROS but also for RNS.26 
The hydroxyl groups dominate the capability of flavonoids 
as antioxidant.10. 
 Diabetes mellitus is characterized by postprandial 
hyperglycemia over a prolonged period, which may be 
due to resistance to insulin action and/or inadequate 
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Figure 4. Two-dimension (2D) simulation by docking analysis for Acarbose (A), GA (B), QUE (C) and RUT (D).
insulin secretion.27 Inhibition of digestive enzymes (such 
as α-glucosidase and α-amylase) that hydrolyze dietary 
polysaccharide into glucose is crucial for controlling glucose 
blood level. Therefore, inhibitors that target α-glucosidase 
serve as a key strategy in the treatment of diabetes 
mellitus. In the present work, the potential inhibition of the 
compounds on α-glucosidase activity was evaluated. 
 All compounds showed significant inhibition on 
α-glucosidase compared to acarbose, with QUE almost 
13 times more active than acarbose, whereas GA and 
RUT almost 4 times stronger than acarbose. Through the 
enzyme kinetic study, GA and RUT were shown to act as 
competitive  inhibitors  on  α-glucosidase,  similar  to  that 
found for acarbose. These results suggest that GA, RUT, 
and acarbose inhibited α-glucosidase by binding with 
free enzyme in a manner that prevents substrate binding. 
These findings are in accordance with previous studies by 
Zhang, et al, and Proença, et al. 28,29 On the other hand, QUE 
inhibited α-glucosidase in a mixed type of competitive and 
noncompetitive inhibition. This observation indicates that 
QUE may form enzyme-inhibitor complex and form substrate 
– inhibitor to interrupt enzyme-substrate intermediate. It is 
likely that the mixed type inhibition enables QUE to inhibit 
α-glucosidase in a broader binding sites compared to GA, 
RUT and acarbose as competitive inhibitors, giving rise to 
the lowest IC
50 
value observed for QUE. 
In order to further understand the binding mechanism 
at molecular level, molecular docking analysis was 
performed between α-glucosidase and each compound. 
In all ligand-receptor models, the hydrogen bonds are the 
main drivers involved for the interaction of each docked 
ligand to α-glucosidase. At α-glucosidase binding site, GA 
showed two H-interactions with Ser240 and Ser241, and 
one interaction of H-pi with Tyr158. Two H-bonds were 
observed between QUE and active site residues Glu411 and 
Asp215. Five H-bonds were formed between RUT with the 
amino acid residues Asp242, Ser311, Leu313, Gln279 and 
Glu411, whereas the competitive inhibitor acarbose showed 
one H-bond interaction with Asp242. It is worth pointing 
that GA, RUT and acarbose occupy the same active sites 
at α-glucosidase to avoid the entrance of the substrate 
pNPG. The binding sites observed by docking simulations 
supported the competitive type of inhibition obtained from 
kinetic experimental assay for these compounds.
 The docking energy calculated for all the tested 
compounds further supported the experimental results.  The 
predicted free energy calculated for GA, QUE, and RUT 
were lower than acarbose. This result confirms the stronger 
inhibitory activities of these compounds on α-glucosidase 
when compared with acarbose. In addition, the predicted Ki 
values for QUE and RUT (Ki = 12.8 and 0.36, respectively) 
were also lower than acarbose (Ki = 69.66), indicating 
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that QUE and RUT have more affinity for α-glucosidase 
compared to acarbose.
Conclusion
The present study found that flavonoids like QUE and 
RUT are good antioxidants. QUE and RUT are also good 
inhibitors for α-glucosidase activity, with inhibition 
activities better than the standard compound acarbose, thus 
can be effective in reducing post-prandial hyperglycemia 
(PPHG). These findings may facilitate further research for 
the development and application of these compounds as 
α-glucosidase inhibitors and ingredients in functional food.
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